John Riley, MD
Internal Medicine · Fishers, INNPI 1841394830
Payments from drug & device makers
Across 23 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$131
- Collegium Pharmaceutical, Inc.$92
- Avita Medical Americas, LLC$64
- Sunovion Pharmaceuticals Inc.$59
- Abbott$29
- Johnson & Johnson$15
- plus $14 from 1 others
What the payments were for
- Food & beverage$405100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 8 | $131 |
| Collegium Pharmaceutical, Inc. | 6 | $92 |
| Avita Medical Americas, LLC | 1 | $64 |
| Sunovion Pharmaceuticals Inc. | 5 | $59 |
| Abbott | 1 | $29 |
| Johnson & Johnson | 1 | $15 |
| Tris Pharma Inc | 1 | $14 |
How this compares
$405 in reported general payments places this provider in the 60th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 12 | $16,849 |
| Divalproex Sodium | 73 | $2,899 |
| Ziprasidone Hcl | 30 | $2,808 |
| Divalproex Sodium ErDivalproex Sodium | 40 | $1,835 |
| Methylphenidate ErMethylphenidate Hcl | 21 | $1,191 |
| Haloperidol | 16 | $1,185 |
| Clobazam | 12 | $744 |
| Quetiapine Fumarate | 19 | $725 |
| Acyclovir | 53 | $685 |
| Valsartan | 13 | $661 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 51 | $656 |
| Trazodone Hcl | 72 | $524 |
| Fludrocortisone Acetate | 14 | $490 |
| Fluoxetine Hcl | 17 | $486 |
| Tamsulosin Hcl | 15 | $422 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Fishers
- Peter CaccavalloFishers$19K
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.